Franziska is an expert in bringing life science innovation to patients faster and more effectively and brings 15 years of experience in the pharma and biotech industry.
Franziska is an associate director in Arthur D. Little’s Frankfurt office and leads our Healthcare/Life Science services for Central Europe (Germany/Switzerland). She is focused on the life sciences and healthcare sector, specifically working in pharmaceutical R&D and commercial operations for innovative technologies such as biologics and new modalities. Franziska is an experienced management consultant and industry expert with more than 15 years of working experience in the global pharma and biotech industry.
Her work includes strategy development (R&D and commercial), opportunity assessment, development of strategies to enter or scale new business models including operations (biologics, biosimilar), complex program delivery, operational & commercial due diligence, change management, and program management for healthcare suppliers (pharma, biotech and CMO/CDMO).
Before joining Arthur D. Little, Franziska spent more than 12 years working in the pharma industry, focusing on end-to-end innovation and development of biologics (CMC, R&D and go-to-market launch strategies), especially in oncology, cardiovascular and rare disease indication, with focus on integrated fast-to-market approaches.
She is skilled in stakeholder management, change management and collaboration, and combines in-depth understanding of technology with strong analytical and strategic skills. Having worked in R&D/high-tech and commercial environments, Franziska is comfortable communicating in both of these worlds, as well as interacting at board level.
Franziska is passionate about driving the next wave of innovations and bringing these to patients in a sustainable manner.